Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
58,272,553
-
Total 13F shares
-
59,963,279
-
Share change
-
+212,062
-
Total reported value
-
$1,757,322,194
-
Put/Call ratio
-
112%
-
Price per share
-
$29.30
-
Number of holders
-
216
-
Value change
-
-$10,187,060
-
Number of buys
-
107
-
Number of sells
-
114
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) as of Q1 2025
As of 31 Mar 2025,
AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) was held by
216 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,963,279 shares.
The largest 10 holders included
FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc., Bellevue Group AG, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, Erste Asset Management GmbH, COMMODORE CAPITAL LP, ARMISTICE CAPITAL, LLC, and MACQUARIE GROUP LTD.
This page lists
216
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.